Introduction to Oncology Counselling
Oncology counselling is a specialised branch of genetic counselling that focuses on identifying and managing hereditary cancer risks in adults. Its primary aim is to provide individuals and families with clear, evidence-based guidance about their genetic predisposition to various cancers.
Understanding one’s inherited risk is crucial, as it allows for early intervention, tailored screening programmes, and preventive strategies that can significantly reduce cancer incidence and improve long-term outcomes. Through oncology counselling, patients gain insight not only into their personal risk but also into how it may affect close relatives, enabling informed decision-making for the whole family.
The role of genetic counselling in this context extends beyond simply interpreting test results. It encompasses education, psychological support, and practical guidance, helping adults navigate complex medical information, consider lifestyle modifications, and explore options such as enhanced surveillance or prophylactic interventions.
Identifying Hereditary Cancer Risks
A key component of oncology counselling is the identification of hereditary cancer risks. This process begins with a detailed assessment of the individual’s family medical history, looking for patterns of cancer that may suggest a genetic predisposition. Understanding these familial trends allows clinicians to estimate the likelihood of inherited mutations and tailor preventive strategies accordingly.
Certain genes are strongly associated with familial cancer syndromes. For example:
-
BRCA1 and BRCA2: Mutations in these genes significantly increase the risk of breast and ovarian cancers, and are central to hereditary breast-ovarian cancer syndromes.
-
Lynch Syndrome (MLH1, MSH2, MSH6, PMS2): Mutations in these DNA repair genes predispose individuals to colorectal, endometrial, and other cancers, often at a younger age than sporadic cases.
Through genetic counselling, patients are educated about these risks, the implications for themselves, and the potential impact on their relatives. This empowers informed decision-making regarding genetic testing, screening schedules, and preventive interventions, ensuring that cancer risk management is both personalised and proactive.
| Gene / Syndrome | Associated Cancers | Inheritance Pattern | Screening Recommendations |
|---|---|---|---|
| BRCA1 / BRCA2 | Breast, Ovarian, Prostate | Autosomal dominant | Enhanced mammography and MRI; consider prophylactic mastectomy or oophorectomy; regular clinical exams |
| Lynch Syndrome (MLH1, MSH2, MSH6, PMS2) | Colorectal, Endometrial, Ovarian, Gastric | Autosomal dominant | Early and frequent colonoscopy; surveillance for related cancers; consider prophylactic surgeries if indicated |
| TP53 (Li-Fraumeni Syndrome) | Breast, Sarcomas, Brain, Adrenal | Autosomal dominant | Whole-body MRI screening; early and frequent imaging; genetic counselling for family members |
| PTEN (Cowden Syndrome) | Breast, Thyroid, Endometrial | Autosomal dominant | Breast MRI and mammography; thyroid ultrasound; dermatologic and GI surveillance |
| CDH1 | Gastric, Lobular Breast | Autosomal dominant | Endoscopic surveillance; prophylactic gastrectomy in high-risk ca |
Genetic Testing in Adult Oncology Counselling
Genetic testing is a cornerstone of adult oncology counselling, enabling identification of inherited mutations that increase cancer risk.
It provides objective information to guide personalised prevention, early detection, and treatment strategies.
Single-gene testing: Focuses on specific genes like BRCA1 or BRCA2 when family history suggests a hereditary syndrome.
Multi-gene panels: Analyse multiple genes simultaneously, including Lynch syndrome genes (MLH1, MSH2, MSH6, PMS2), for broader hereditary cancer assessment.
Whole Exome/Genome Sequencing: Used in complex or atypical cases to uncover rare or unexpected variants across coding regions or the entire genome.
Genetic testing is usually performed on a blood or saliva sample.
Pre-test counselling ensures the patient understands the purpose, potential outcomes, and implications for themselves and their family, supporting informed consent and psychological preparedness.
Pathogenic variants: Indicate increased cancer risk, guiding preventive measures and enhanced surveillance.
Variants of uncertain significance (VUS): Require careful interpretation and may need additional testing or family studies.
Negative results: Offer reassurance but do not fully eliminate risk, especially with strong family history.
Genetic testing informs personalised prevention strategies, including:
- Regular screening programmes (e.g., earlier mammograms or colonoscopies)
- Lifestyle modifications to reduce cancer risk
- Consideration of prophylactic surgeries or medications for high-risk individuals
Key Takeaway:
Genetic testing in adult oncology counselling enables personalised prevention and early detection strategies, empowering patients and clinicians to make informed decisions about cancer risk management.
Risk Management and Preventive Strategies
A crucial aspect of oncology counselling is translating genetic insights into actionable risk management and preventive strategies. Once a hereditary cancer risk is identified, patients can work with healthcare professionals to implement personalised plans that minimise risk and optimise long-term health.
Lifestyle Modifications and Medical Surveillance
Even with a genetic predisposition, lifestyle changes can play a significant role in reducing overall cancer risk. Examples include:
-
Maintaining a healthy diet and body weight
-
Engaging in regular physical activity
-
Avoiding tobacco and limiting alcohol consumption
-
Staying up to date with vaccinations and screenings
In addition to lifestyle adjustments, enhanced medical surveillance is essential. This may involve:
-
Earlier and more frequent imaging (e.g., mammograms, MRI, colonoscopies)
-
Regular clinical examinations for high-risk tissues
-
Biomarker monitoring for early detection of disease
Preventive Interventions
For individuals at particularly high risk due to pathogenic genetic variants, preventive medical interventions may be recommended:
-
Prophylactic surgery: For example, mastectomy or oophorectomy in BRCA1/BRCA2 mutation carriers
-
Chemoprevention: Using medications such as selective estrogen receptor modulators (SERMs) to reduce cancer risk
-
Targeted therapies: In some cases, emerging personalised drugs may be used to modify risk or delay disease onset
Psychological and Ethical Considerations in Oncology Counselling
Oncology counselling addresses not only genetic testing and medical management but also the psychological and ethical aspects of hereditary cancer risk. Understanding these dimensions is essential for providing comprehensive care and supporting patients and their families.
Hover over each box to explore key psychological and ethical considerations!
Receiving news of elevated genetic cancer risk can cause anxiety, fear, or guilt.
Genetic counselling offers a supportive environment where patients can:
- Discuss concerns openly with trained professionals
- Receive guidance on coping strategies and emotional resilience
- Understand their options without pressure
This ensures patients make calm, informed decisions rather than acting impulsively under stress.
Hereditary cancer risks often impact relatives who may carry the same mutations.
Ethical considerations include:
- Disclosure to family members: Guidance on when and how to inform relatives
- Reproductive decisions: Considering implications for children or future generations
- Informed consent: Ensuring patients fully understand the consequences of testing
Addressing these challenges empowers patients to make responsible choices, balancing personal autonomy with family duty.
Key Takeaway:
Comprehensive oncology counselling includes psychological support and ethical guidance, ensuring patients and families navigate hereditary cancer risks with informed, responsible decision-making.
Case Studies and Practical Applications
Real-world examples illustrate how oncology counselling translates genetic insights into practical strategies that guide treatment decisions and preventive care for adults at risk of hereditary cancers.
Case 1: BRCA Mutation Carrier
A 36-year-old woman with a family history of breast and ovarian cancer underwent genetic counselling and tested positive for a BRCA1 mutation. Through oncology counselling:
-
She received education about her elevated risk and options for early detection.
-
A personalised plan was implemented, including enhanced surveillance (MRI, mammography) and discussion of prophylactic surgery.
-
Family members were offered cascade testing to determine their risk.
This case demonstrates how genetic counselling empowers patients to make informed decisions, reducing uncertainty and guiding effective prevention strategies.
Case 2: Lynch Syndrome in Adults
A 42-year-old man with multiple relatives affected by colorectal cancer received oncology counselling and genetic testing confirmed Lynch syndrome. Outcomes included:
-
Targeted surveillance: Early and regular colonoscopies to detect precancerous lesions.
-
Lifestyle recommendations: Diet, exercise, and avoidance of tobacco/alcohol to reduce cancer risk.
-
Family guidance: Encouraging at-risk relatives to undergo genetic testing and follow appropriate surveillance.
This example highlights how oncology counselling not only supports early detection but also allows families to take proactive preventive measures, minimising future cancer risk.
Key Takeaways from Case Studies
-
Oncology counselling bridges the gap between genetic risk and practical action.
-
Genetic testing informs personalised screening and preventive strategies.
-
Cascade testing benefits families, improving health outcomes across generations.
Conclusion: The Value of Oncology Counselling
Oncology counselling plays a pivotal role in identifying hereditary cancer risks, guiding preventive strategies, and supporting informed decision-making for adults.
By combining genetic counselling, personalised risk assessment, and proactive management plans, healthcare providers can reduce cancer incidence and improve outcomes for patients and their families.
Early engagement with oncology counselling allows individuals to:
- Understand their genetic predisposition and associated risks
- Make informed decisions about screening, preventive interventions, and lifestyle modifications
- Extend the benefits of cascade testing to at-risk family members
From Insight to Action:
– Identify hereditary cancer risks through genetic counselling.
– Implement personalised prevention and screening strategies.
– Support informed decision-making for patients and families.
Why Oncology Counselling Matters:
Integrating oncology counselling into adult healthcare transforms reactive care into proactive, personalised cancer prevention, reducing uncertainty and empowering patients with actionable knowledge.
Your Next Step:
If you or a family member may be at risk of hereditary cancer, consider booking a consultation with a qualified genetic counsellor to enable early prevention, detection, and long-term health benefits.
